Phoenix Children’s Hospital and Molecular Medicine

A veteran of the investment industry, John W. Pacheco founded Financial American Corporation and served as chief executive officer for more than three decades. John W. Pacheco now leverages his success to contribute to a number of organizations, including the Phoenix Children’s Hospital.

The Phoenix Children’s Hospital currently seeks financial support in the areas of emergency and trauma, the Hope Fund, and molecular medicine. The following explains more about molecular medicine.

1. Molecular medicine allows health-care professionals to look at an individual’s deoxyribonucleic acid (DNA) to plan a course treatment. This type of science is the first of its kind that caters specifically to individual patient care.

2. This innovation utilizes gene sequencing and testing to determine sensitivity to new drugs. Identifying potential mutations, physicians can administer treatments that are less likely to cause adverse side effects.

3. By analyzing genetic susceptibility to diseases, molecular medicine paves the way for researchers to develop future methods that will aid in the prevention of cancer and other illnesses.

Advertisements

JDRF and Eli Lilly Launch Two-Year $1.8 Million Partnership

John W. Pacheco serves as chief executive officer of Financial American Corporation, a Scottsdale, Arizona-based firm he founded in 1978. Outside of his professional activities, John W. Pacheco supports the work of a number of philanthropic organizations, including the Juvenile Diabetes Research Foundation (JDRF).

In a recent press release, JDRF announced that it has launched a two-year partnership with Eli Lilly and Company to provide increased support for patients diagnosed with type 1 diabetes (T1D). Through the partnership, JDRF will receive $1.8 million for its various diabetes support programs and events, including Bag of Hope, the TypeOneNation Summits, and the JDRF One Walk.

The funds will also help JDRF continue to distribute its teen and school advisory toolkits and support the Children’s Congress, which brings 150 child delegates and their families to Washington, DC, every two years to raise awareness about the importance T1D research funding. Eli Lilly has been instrumental in supporting these and other JDRF initiatives since it became one of the group’s national sponsors more than four years ago.